(Q33448696)
Statements
1 reference
A phase IV, double-blind, multicentre, randomized, placebo-controlled, pilot study to assess the feasibility of switching individuals receiving efavirenz with continuing central nervous system adverse events to etravirine (English)
1 reference
Alan Winston
1 reference
Laura Waters
1 reference
Martin Fisher
1 reference
Chris Higgs
1 reference
Wendy Hadley
1 reference
Lucy Garvey
1 reference
Sundhiya Mandalia
1 reference
Nicky Perry
1 reference
Mackie Nicola
1 reference
Mark Nelson
1 reference
1 January 2011
1 reference
1 reference
25
1 reference
65-71
1 reference
Identifiers
1 reference
1 reference